[99MTechnetium-fibrinogen labeling using electrolytic zircuronium release].

An electrolytic method for labelling fibrinogen with zirconium as a reductant for 99mTc is presented. The optimal labelling conditions and the in-vitro screening are subject of the study. First clinical experience indicates that the substance is clottable in vivo and applicable for localization.